J Holloman - BlackRock Health Independent Trustee
BME Etf | USD 38.66 0.31 0.81% |
Age | 66 |
Tenure | 3 years |
Address | 50 Hudson Yards, New York, NY, United States, 10001 |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/24022 |
J Holloman Latest Insider Activity
Tracking and analyzing the buying and selling activities of J Holloman against BlackRock Health etf is an integral part of due diligence when investing in BlackRock Health. J Holloman insider activity provides valuable insight into whether BlackRock Health is net buyers or sellers over its current business cycle. Note, BlackRock Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
J Holloman over three months ago Acquisition by J Holloman of 856 shares of BlackRock Credit subject to Rule 16b-3 | ||
J Holloman over three months ago Acquisition by J Holloman of 943 shares of BlackRock Credit at 9.54 subject to Rule 16b-3 | ||
J Holloman over six months ago Acquisition by J Holloman of 661 shares of BlackRock Credit subject to Rule 16b-3 | ||
J Holloman over six months ago Insider Trading |
BlackRock Health Management Efficiency
BlackRock Health's management efficiency ratios could be used to measure how well BlackRock Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
Showing other executives | One Year Return | ||
Jason Yablon | Cohen Steers Qualityome | 41 | |
Keith Quinton | Eaton Vance Tax | 63 | |
Mark Fetting | Eaton Vance Tax Managed | 67 | |
Robert Fairbairn | BlackRock Science Tech | 56 | |
Marcus Smith | Eaton Vance Tax Managed | 55 | |
R Hubbard | Blackrock Innovation Growth | 63 | |
W Kester | Blackrock Innovation Growth | 70 | |
Charles Park | Blackrock Innovation Growth | 54 | |
Jane Magpiong | Cohen Steers Qualityome | 60 | |
Eric Stein | Eaton Vance Enhanced | 41 | |
W Kester | Blackrock Resources Commodities | 70 | |
Jay Fife | Blackrock Innovation Growth | 51 | |
Marcus Smith | Eaton Vance Enhanced | 55 | |
Deidre Walsh | Eaton Vance Tax | 50 | |
W Kester | Blackrock Enhanced Capital | 70 | |
Robert Fairbairn | Blackrock Innovation Growth | 56 | |
Ramona Rogerswindsor | Cohen Steers Qualityome | 60 | |
Edward Perkin | Eaton Vance Tax Managed | 49 | |
Jonathan Diorio | Blackrock Innovation Growth | 41 | |
Phillip Holloman | Blackrock Enhanced Capital | 65 | |
Scott Wennerholm | Eaton Vance Enhanced | 62 |
Management Performance
Return On Equity | 0.0901 | ||||
Return On Asset | 0.0017 |
BlackRock Health Sciences Money Managers
CFA CFA, Portfolio Mang | ||
Erin Xie, Portfolio Manager | ||
Robert Hubbard, Independent Trustee | ||
Karen Robards, Independent Vice Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer and Anti- Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Xiang Liu, Portfolio Manager | ||
Cynthia Egan, Independent Trustee | ||
Kyle CFA, Portfolio Manager | ||
Jay Fife, Treasurer | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Christopher Accettella, Portfolio Manager | ||
Thomas CFA, Portfolio Manager | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Jeffrey Lee, Portfolio Manager | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0901 | ||||
Return On Asset | 0.0017 | ||||
Profit Margin | 6.84 % | ||||
Operating Margin | 0.21 % | ||||
Current Valuation | 542.61 M | ||||
Shares Outstanding | 13.6 M | ||||
Shares Owned By Institutions | 23.04 % | ||||
Number Of Shares Shorted | 8.01 K | ||||
Price To Earning | 6.69 X | ||||
Price To Book | 0.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.